ClinicalTrials.gov
ClinicalTrials.gov Menu

Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement (THR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03120312
Recruitment Status : Not yet recruiting
First Posted : April 19, 2017
Last Update Posted : April 19, 2017
Sponsor:
Information provided by (Responsible Party):
Zheng Guo, Second Hospital of Shanxi Medical University

Brief Summary:
The is a retrospective analysis to study the characteristics of elderly patients treated with total hip replacements during past 5 years.

Condition or disease Intervention/treatment
Total Hip Replacement Procedure: total hip replacement

Detailed Description:
Patients underwent total hip replacement due to removal of the hip caused by retrogressive lesions, is conducive to the improvement of hip function .But at the same time,the complications from patients accepted total hip replacement surgery will directly or indirectly affect the prognosis of the patients, resulting in patients with delayed recovery and increase the hospitalization time and cost. Serious complications can lead to patients deaths during perioperative period. This study was designed to provide a retrospective analysis of postoperative recovery, quality of life, and complications in patients undergoing hip replacement over the past five years, providing data for clinical studies.

Study Type : Observational
Estimated Enrollment : 1500 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacements During Past 5 Years :A Retrospective Analysis
Estimated Study Start Date : May 30, 2017
Estimated Primary Completion Date : December 30, 2017
Estimated Study Completion Date : December 30, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hip Replacement


Intervention Details:
  • Procedure: total hip replacement
    primary hip replacement patients during past 5 years.


Primary Outcome Measures :
  1. Quality of life during 5 years after surgery [ Time Frame: 5 years ]
    evaluate the quality of life after surgery by WHO QOL-BREF scale with interview ,WHO QOL-BREF scale includes five aspects: physical, psychological, social, environmental, integrated, divided into five levels


Secondary Outcome Measures :
  1. The incidence of postoperative complications [ Time Frame: from 7 days to 1 year ]
    Participants will be followed for the incidence of postoperative complications

  2. Mortality during 5 years after surgery [ Time Frame: during 5 years ]
    Participants will be followed for Survival rate during 5 years after surgery



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years to 89 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
From January 2012 to July 30,2017,approximately 1500 cases of primary hip replacement in this study,including male ,female and bilateral replacements.
Criteria

Inclusion Criteria:

  1. ASA Ⅱ-Ⅲ,elective operation patients,
  2. NO other severe complication history

Exclusion Criteria:

  1. Having severe comorbidity
  2. not for the first time of joint replacement
  3. Suffered from neurologic disorder or impaired mental state

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03120312


Contacts
Contact: Zheng Guo 89351-3365108 guozheng713@163.com
Contact: Lili Wang 15834058006 15834058006@163.com

Locations
China, Shanxi
Second of Shanxi Medical University
Taiyuan, Shanxi, China, 030001
Sponsors and Collaborators
Second Hospital of Shanxi Medical University
Investigators
Study Chair: Zheng Guo Second Hospital of Shanxi Medical University